Skip to main content

Publisher: Elsevier

Volume 6, Number 3, 6 February 1996

Irreversible inhibitions of serine proteases by peptidyl allylic halide derivatives
pp. 219-224(6)
Authors: Ohba, T.; Ikeda, E.; Wakayama, J.; Takei, H.

Favourites:
ADD

In vivo potent antifilarial -carbolines
pp. 225-228(4)
Authors: Agarwal, A.; Agarwal, S.K.; Singh, S.N.; Fatma, N.; Chatterjee, R.K.

Favourites:
ADD

Disruption of coiled coil formation by methionine oxidation
pp. 229-232(4)
Author: Garcia-Echeverria, C.

Favourites:
ADD

Caracasandiamide, a truxinic hypotensive agent from Verbesina caracasana
pp. 233-238(6)
Authors: Costaras, N.E.; Monache, G.D.; Botta, B.; Monache, F.D.; Espinal, R.; de Bonnevaux, S.C.; de Luca, C.; Botta, M.; Corelli, F.; dei, D.; Gacs-Baitz, E.; Carmignani, M.

Favourites:
ADD

Synthesis and Biological Activity of Conformationally Constrained Sialyl Lewis X Analogues with Reduced Carbohydrate Character.
pp. 239-244(6)
Authors: Bamford, M.J.; Gore, P.M.; Holmes, D.S.; Prodger, J.C.; Saez, V.; Bird, M.; Priest, R.

Favourites:
ADD

Synthesis and biological activity of the neuronal calcium channel blocker 2-amino-1-(2,5-dimethoxyphenyl)-5-trifluoromethyl benzimidazole (NS-649).
pp. 245-248(4)
Authors: Varming, T.; Christophersen, P.; MOller, A.; Peters, D.; Axelsson, O.; Nielsen, E.

Favourites:
ADD

Quinoline-substituted dihydroindoles as cysLT1 (LTD4 receptor) antagonists
pp. 249-252(4)
Authors: Sawyer, J.S.; Thrasher, K.J.; Bach, N.J.; Stengel, P.W.; Cockerham, S.L.; Silbaugh, S.A.; Roman, C.R.; Froelich, L.L.; Fleisch, J.H.

Favourites:
ADD

Phosphonic acid and phosphinic acid tripeptides as inhibitors of glutathionylspermidine synthetase
pp. 253-258(6)
Authors: Verbruggen, C.; de Craecker, S.; Rajan, P.; Xian-Yun, J.; Borloo, M.; Smith, K.; Fairlamb, A.H.; Haemers, A.

Favourites:
ADD

Synthesis of (+/-)-10,10-dimethylhuperzine A - A huperzine analogue possessing a slower enzyme off-rate
pp. 259-262(4)
Authors: Kozikowski, A.P.; Ding, Q.; Saxena, A.; Doctor, B.P.

Favourites:
ADD

Serotoninergic 5-HT3 and 5-HT4 receptor activities of dihydrobenzofuran carboxylic acid derivatives.
pp. 263-266(4)
Authors: Fancelli, D.; Caccia, C.; Fornaretto, M.G.; McArthur, R.; Severino, D.; Vaghi, F.; Varasi, M.

Favourites:
ADD
Favourites:
ADD

Design of dual-acting thromboxane antagonist-synthase inhibitors by a mutual prodrug approach
pp. 273-278(6)
Authors: Shine, B.; Brown, G.R.; Clarke, D.S.; Faull, A.W.; Foubister, A.J.; Smithers, M.J.

Favourites:
ADD

Synthesis and Analgesic Activity of Epibatidine Analogues
pp. 279-282(4)
Authors: Rui, X.; Donglu, B.; Guohua, C.; Jining, T.; Xingzu, Z.

Favourites:
ADD

First synthesis of enantiomerically pure carbocyclic oxanosine as a potential chemotherapeutic agent
pp. 283-286(4)
Authors: Bunge, J.; Cohen-Rosenthal, E.; Ruiz-Quintanilla, A.; Kurata, H.; Nishiyama, S.; Yamamura, S.; Kato, K.; Fujiwara, S.; Umezawa, K.

Favourites:
ADD

Potent α-ketocarbonyl and boronic ester derived inhibitors of proteasome
pp. 287-290(4)
Authors: Iqbal, M.; Chatterjee, S.; Kauer, J.C.; Mallamo, J.P.; Messina, P.A.; Reiboldt, A.; Siman, R.

Favourites:
ADD

Synthesis of (-)-3(R)-amino-4(R),5(R)-dihydroxy-1-cyclohexene-1-carboxylic acid: the 3(R)-amino analogue of (-)-shikimic acid
pp. 291-294(4)
Authors: Brettle, R.; Cross, R.; Frederickson, M.; Haslam, E.; Davies, G.M.

Favourites:
ADD

Design and synthesis of ring-constrained boropeptide thrombin inhibitors
pp. 295-300(6)
Authors: Fevig, J.M.; Abelman, M.M.; Brittelli, D.R.; Kettner, C.A.; Knabb, R.M.; Weber, P.C.

Favourites:
ADD

Synthesis of conformationally-restricted boropeptide thrombin inhibitors
pp. 301-306(6)
Authors: Cacciola, J.; Fevig, J.M.; Alexander, R.S.; Brittelli, D.R.; Kettner, C.A.; Knabb, R.M.; Weber, P.C.

Favourites:
ADD

L-162,389: a potent orally active angiotensin II receptor antagonist with balanced affinity to both AT1 and AT2 receptor subtypes.
pp. 307-310(4)
Authors: Rivero, R.A.; Kevin, N.J.; Kivlighn, S.D.; Zingaro, G.J.; Chang, R.S.; Greenlee, W.J.

Favourites:
ADD

Benzylphosphonic acid inhibitors of human prostatic acid phosphatase
pp. 311-314(4)
Authors: Schwender, C.F.; Beers, S.A.; Malloy, E.A.; Cinicola, J.J.; Wustrow, D.J.; demarest, K.D.; Jordan, J.

Favourites:
ADD
Favourites:
ADD

Quantification of the extent of attenuation of the rate of turnover chemistry of the TEM-1 -lactamase by the α-1R-hydroxyethyl group in substrates
pp. 319-322(4)
Authors: Bloemkolk, J.W.; van der Schaaf, R.J.; Miyashita, K.; Massova, I.; Mobashery, S.

Favourites:
ADD

Phosphinic acid inhibitors of matrix metalloproteinases
pp. 323-328(6)
Authors: Zwetsloot, G.I.J.M.; Geyer, A.; Caldwell, C.G.; Sahoo, S.P.; Polo, S.A.; Eversole, R.R.; Lanza, T.J.; Mills, S.G.; Niedzwiecki, L.M.; Izquierdo-Martin, M.; Chang, B.C.; Harrison, R.K.; Kuo, D.W.; T.-Y., L.; Stein, R.L.; Durette, P.L.; Hagmann, W.K.

Favourites:
ADD

Inhibition of matrix metalloproteinases by P1 substituted N-carboxyalkyl dipeptides
pp. 329-332(4)
Authors: Chapman, K.T.; Wales, J.; Sahoo, S.P.; Niedzwiecki, L.M.; Izquierdo-Martin, M.; Chang, B.C.; Harrison, R.K.; Stein, R.L.; Hagmann, W.K.

Favourites:
ADD

Potential anxiolytic agents. 2. Improvement of oral efficacy for the pyrido[1,2-a]benzimidazole (PBI) class of GABA-A receptor modulators
pp. 333-338(6)
Authors: de Bruijn, T.J.N.M.; Coenen, F.H.J.M.; Lulofs, K.R.D.; Maryanoff, B.E.; McComsey, D.F.; Ho, W.; Shank, R.P.; Dubinsky, B.

Favourites:
ADD

Design, synthesis and in vitro activities of a series of benzimidazole/benzoxazole glycoprotein IIb/IIIa inhibitors
pp. 339-344(6)
Authors: Chu-Biao, X.; Rafalski, M.; Roderick, J.; Eyermann, C.J.; Mousa, S.; Olson, R.E.; deGrado, W.F.

Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more